Announced that The Brazilian regulatory agency ANVISA has ap...

manyjackie wrote a post · Sep 23, 2021 02:39

Announced that The Brazilian regulatory agency ANVISA has approved the commencement of additional Phase 3 clinical trials of Leronlimab in certain Novel Coronavirus-19 patients.

The trial will focus on hospitalized critically ill patients requiring mechanical and invasive ventilation or extracorporeal membrane oxygenation. $CYTODYN INC(CYDY.US)$

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3958 Views

Comment

manyjackie

260Followers

17Following

573Visitors